Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds

radionuclide therapy

  • You have access
    The MIRD Schema for Radiopharmaceutical Dosimetry: A Review
    Pat Zanzonico
    Journal of Nuclear Medicine Technology June 1, 2024, 52 (2) 74-85; DOI: https://doi.org/10.2967/jnmt.123.265668
  • α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States
    You have access
    α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States
    Kritika Subramanian, Judith Stangl-Kremser, Lady Sawoszczyk, Vasilios Avlonitis, Andrew Gernerd, Kyla Nixon, Michael Zgaljardic, Scott Tagawa, Neil Bander and Joseph R. Osborne
    Journal of Nuclear Medicine Technology September 1, 2023, 51 (3) 215-219; DOI: https://doi.org/10.2967/jnmt.122.265166
  • You have access
    177Lu-PSMA Therapy
    Ephraim E. Parent, Bital Savir-Baruch, Isis W. Gayed, Frankis Almaguel, Bennett B. Chin, Austin R. Pantel, Evan Armstrong, Amanda Morley, Robin C. Ippisch and Robert R. Flavell
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 205-212; DOI: https://doi.org/10.2967/jnmt.122.263814
  • You have access
    Nuts and Bolts of 223Ra-Dichloride Therapy
    Erin Grady
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 215-221; DOI: https://doi.org/10.2967/jnmt.122.263812
  • Stability Matters: Radiochemical Stability of Therapeutic Radiopharmaceutical <sup>177</sup>Lu-PSMA I&amp;T
    You have access
    Stability Matters: Radiochemical Stability of Therapeutic Radiopharmaceutical 177Lu-PSMA I&T
    Madhusudan Vyas, Remy Lim, Jessica Fagan and Rudresh Chandrashekar
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 244-247; DOI: https://doi.org/10.2967/jnmt.121.262423
  • Estimation of Chest Wall Attenuation of <sup>123</sup>I Emissions in Substernal Goiter: A Phantom Study
    You have access
    Estimation of Chest Wall Attenuation of 123I Emissions in Substernal Goiter: A Phantom Study
    Matthew Alfano, John Weaver, Richard Mazurek and Alan Siegel
    Journal of Nuclear Medicine Technology September 1, 2021, 49 (3) 232-234; DOI: https://doi.org/10.2967/jnmt.120.260810
  • You have access
    Guidance on 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division
    Amanda Abbott, Christopher G. Sakellis, Eric Andersen, Yuji Kuzuhara, Lauren Gilbert, Kelly Boyle, Matthew H. Kulke, Jennifer A. Chan, Heather A. Jacene and Annick D. Van den Abbeele
    Journal of Nuclear Medicine Technology September 1, 2018, 46 (3) 237-244; DOI: https://doi.org/10.2967/jnmt.118.209148
  • You have access
    Technical Advances in Image Guidance of Radionuclide Therapy
    Casper Beijst, Britt Kunnen, Marnix G.E.H. Lam and Hugo W.A.M. de Jong
    Journal of Nuclear Medicine Technology December 1, 2017, 45 (4) 272-279; DOI: https://doi.org/10.2967/jnmt.117.190991
  • You have access
    Release of Patients Containing Therapeutic Dosages of Iodine-131 from Hospitals
    James E. Carey, Thomas M. Kumpuris and Mark C. Wrobel
    Journal of Nuclear Medicine Technology September 1, 1995, 23 (3) 144-149;
  • You have access
    A Difficult Therapeutic Problem with a Nuclear Medicine Solution: A Case Report
    James Corley, Jeannie Yoder and George Burke
    Journal of Nuclear Medicine Technology September 1, 1995, 23 (3) 195-196;

Pages

  • Next
  • 1
  • 2
SNMMI

© 2025 SNMMI

Powered by HighWire